Bleeding and Thromboembolic Outcomes Following GLP-1 Receptor Agonist Initiation in Patients With Type 2 Diabetes and Atrial Fibrillation Receiving Direct Oral Anticoagulants: A Target Trial Emulation
Diabetes, obesity & metabolism · 2026 Nov 3 · Du F, Cicali B, Singh Ospina NM et
MH
By Maren Holt · Senior Reporter, GLP-1
Nov 2 19:00 ETSource: Diabetes, obesity & metabolism
From the source
Read at pubmed.ncbi.nlm.nih.govBleeding and Thromboembolic Outcomes Following GLP-1 Receptor Agonist Initiation in Patients With Type 2 Diabetes and Atrial Fibrillation Receiving Direct Oral Anticoagulants: A Target Trial Emulation
Diabetes, obesity & metabolism · 2026 Nov 3 · Du F, Cicali B, Singh Ospina NM et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42977570/
